AMSTERDAM, June 24 /PRNewswire/ -- Leading events organiser UBM International Media and sister company UBM Sinexpo todayannounced that a record attendance of 26,547 at its 2010 Chinese Pharma events cluster -- CPhI China for intermediates and APIs; P-MEC for equipment and machinery; plus trails for ICSE Contract Services; and BioPh for the biopharma sector -- representing
Exhibitor figures were also surpassed at the 2010 events, attracting 1,391 exhibitors at CPhI China and 330 at P-MEC China, from a total of 18 countries. On-site space bookings for the 2011 events, scheduled for 21-23 June 2011, again at Shanghai New International Expo Centre, are at record levels, with both existing and new exhibitors signing up in line with rapidly accelerating market growth.
"The continued growth of our China events is testament to the strength of the Chinese pharma market, which is projected to be the third largest pharma market globally by 2011 and second largest by 2020," commented Eliane van Doorn, UBM International Media's Group Director for Pharma Events. "We have witnessed significant growth in the number of Western visitors year-on-year, and the fact that we saw an increase of 13% at this year's events is a reflection of changes within the industry, such as those to local GMP standards, which make sourcing in China increasingly appealing. Factors such as these simply add to the attraction of the many outsourcing and production efficiency partnering opportunities for which China is already globally renowned. This growing demand for outsourcing of contract services has led us to introduce a dedicated ICSE pavilion for the 2011 event."
In addition to the exhibition and networking elements, CPhI China offered over 25 seminars and presentations, many of which were fully booked, and focused on dynamic changes in the Chinese pharmaceutical market and US Quality Standards. Highlights included keynote speakers from Roche, Hovione, Wuxi AppTec and the FDA while a panel discussion carried out a SWOT analysis of the current outsourcing market in China.
Now in its tenth year, CPhI China was joined by ICSE China in 2005, P-MEC China in 2006 and BioPh China in 2010. The events benefit from the support of the China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE) and are organised in conjunction with UBM International Media's sister organisation, UBM Sinexpo. For further information on CPhI China and P-MEC China see: www.cphi-china.com and www.pmec-china.com.
Notes for Editors:
SOURCE UBM International Media
Subscribe to our Free Newsletters!
Angiogenesis is the process of formation of new blood vessels from pre-existing blood vessels. It ...
Aniridia is a genetic eye disorder in which the iris is partially or entirely absent. It is ...
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...View All